Shopping Cart
- Remove All
- Your shopping cart is currently empty
HPN328 is a humanized trispecific T-cell activating construct (TriTAC) that targets CD3 to engage T cells, targets HSA to extend its half-life, and targets DLL3 on tumor cells. It effectively induces T-cell-mediated cytotoxicity against DLL3-expressing small cell lung cancer (SCLC), leading to tumor regression and sustained antitumor immunity. Molecular weight: 53.06 kDa.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | HPN328 is a humanized trispecific T-cell activating construct (TriTAC) that targets CD3 to engage T cells, targets HSA to extend its half-life, and targets DLL3 on tumor cells. It effectively induces T-cell-mediated cytotoxicity against DLL3-expressing small cell lung cancer (SCLC), leading to tumor regression and sustained antitumor immunity. Molecular weight: 53.06 kDa. |
Alias | Hpn328 (Anti-CD3e & DLL3 & Serum Albumin), Hpn328, Gocatamig, MK-6070 |
Cas No. | 2851862-91-2 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.